Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kislay Roy

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nanomedicine (London, England)|November 22, 2017
Recent advances in nanomedicine and survivin targeting in brain cancersJake Mazur, Kislay Roy, Jagat R Kanwar
Biomaterials|August 31, 2015
LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imagingKislay Roy, Rupinder K Kanwar, Jagat R Kanwar
International Journal of Nanomedicine|September 9, 2015
Molecular targets in arthritis and recent trends in nanotherapyKislay Roy, Rupinder Kaur Kanwar, Jagat Rakesh Kanwar
Critical Reviews in Biochemistry and Molecular Biology|September 30, 2011
Chimeric aptamers in cancer cell-targeted drug deliveryJagat R Kanwar, Kislay Roy, Rupinder K Kanwar
Recent Patents on Anti-Cancer Drug Discovery|March 1, 2016
Survivin Modulators: An Updated Patent Review (2011-2015)Kislay Roy, Neha Singh, Rupinder K Kanwar, et al.
Frontiers in Pharmacology|August 13, 2016
Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali BurnKislay Roy, Bhasker Sriramoju, Rupinder K Kanwar, et al.
International Journal of Nanomedicine|July 1, 2015
Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolismGanesh Mahidhara, Rupinder K Kanwar, Kislay Roy, et al.
Journal of Nanobiotechnology|March 2, 2019
Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agentsRajneesh Chaudhary, Kislay Roy, Rupinder Kaur Kanwar, et al.
Journal of Nanobiotechnology|January 18, 2016
Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agentsRajneesh Chaudhary, Kislay Roy, Rupinder Kaur Kanwar, et al.
Nanomedicine (London, England)|December 7, 2010
Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseasesJagat R Kanwar, Rajiv R Mohan, Rupinder K Kanwar, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nanomedicine (London, England)|November 22, 2017
Recent advances in nanomedicine and survivin targeting in brain cancersJake Mazur, Kislay Roy, Jagat R Kanwar
Biomaterials|August 31, 2015
LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imagingKislay Roy, Rupinder K Kanwar, Jagat R Kanwar
International Journal of Nanomedicine|September 9, 2015
Molecular targets in arthritis and recent trends in nanotherapyKislay Roy, Rupinder Kaur Kanwar, Jagat Rakesh Kanwar
Critical Reviews in Biochemistry and Molecular Biology|September 30, 2011
Chimeric aptamers in cancer cell-targeted drug deliveryJagat R Kanwar, Kislay Roy, Rupinder K Kanwar
Recent Patents on Anti-Cancer Drug Discovery|March 1, 2016
Survivin Modulators: An Updated Patent Review (2011-2015)Kislay Roy, Neha Singh, Rupinder K Kanwar, et al.
Frontiers in Pharmacology|August 13, 2016
Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali BurnKislay Roy, Bhasker Sriramoju, Rupinder K Kanwar, et al.
International Journal of Nanomedicine|July 1, 2015
Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolismGanesh Mahidhara, Rupinder K Kanwar, Kislay Roy, et al.
Journal of Nanobiotechnology|March 2, 2019
Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agentsRajneesh Chaudhary, Kislay Roy, Rupinder Kaur Kanwar, et al.
Journal of Nanobiotechnology|January 18, 2016
Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agentsRajneesh Chaudhary, Kislay Roy, Rupinder Kaur Kanwar, et al.
Nanomedicine (London, England)|December 7, 2010
Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseasesJagat R Kanwar, Rajiv R Mohan, Rupinder K Kanwar, et al.
Pageof 3